Daily News Podcast

Smoking tied to localized prostate cancer recurrence, metastasis, death


 

A review and meta-analysis shows that patients with localized prostate cancer who were smokers at the time of local therapy have a high risk of experiencing adverse outcomes and death related to that disease. Also today, teens think their parents approve of marijuana more today than they did in the late 1970’s, switching antimalarials can delay immunosuppressive therapy for patients with cutaneous lupus, and a new reason to eradicate hepatitis C: it can reduce the chance of non-liver cancers.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Endocrinologists well positioned to be experts on changes in transgender care
MDedge Internal Medicine
ACS: Screen for colon cancer at 45
MDedge Internal Medicine
First antidepressant use not tied to first abortion
MDedge Internal Medicine
TAILORx: Most women with intermediate risk ER+ breast cancer can safely skip chemo
MDedge Internal Medicine
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
MDedge Internal Medicine
What is causing my patients’ macrocytosis?
MDedge Internal Medicine
Hip pain predicts arthritis mortality beyond comorbidities
MDedge Internal Medicine
Prostate cancer risk before age 55 higher for black men
MDedge Internal Medicine
Statin effect in prostate cancer may be caused by reduced inflammation
MDedge Internal Medicine
Raised LDL cholesterol, hsCRP tied to polymyalgia rheumatica, GCA
MDedge Internal Medicine